| Net Cash Provided by (Used in) Operating Activities |
1,752,000 |
USD |
-6.3% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-631,000 |
USD |
-8.4% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
185,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
35,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
31,047,801 |
shares |
+0.46% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
1,280,000 |
USD |
+85.5% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
5,081,000 |
USD |
-27.2% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
65,000 |
USD |
+54.8% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
27,527,000 |
USD |
+4.1% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
27,892,000 |
USD |
+2.9% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
3,365,000 |
USD |
+28.1% |
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
684,000 |
USD |
-57.4% |
Q1 2024 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-3,266,000 |
USD |
+40.9% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
3,753,000 |
USD |
+33.4% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
1,075,000 |
USD |
+7% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.05 |
pure |
0% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
-96,000 |
USD |
|
Q2 2023 |
Q2 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
388,000 |
USD |
+1.1% |
Q3 2025 |
Q3 2025 |
| Current Income Tax Expense (Benefit) |
-7,000 |
USD |
+94.7% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
4,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
5,147,000 |
USD |
-14.9% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
365,000 |
USD |
-45.8% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
44,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Interest Expense |
132,000 |
USD |
+2.6% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |